chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Lower lip began to swell up; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar II disorder and OCD (obsessive-compulsive disorder). The patient did not have any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lithium (MANUFACTURER UNKNOWN), olanzapine (MANUFACTURER UNKNOWN) and lamotrigine (MANUFACTURER UNKNOWN) all for an unknown indication from an unknown date and were unknown if ongoing. On 02May2021 at 16:00, approximately two weeks after the vaccination, the patient's lower lip began to swell up. It was reported that the patient's lip ballooned up 2 times its normal size over the course of three days and then the swelling went away. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event lip swelling which included treatment with unspecified steroid cream and pills. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event lower lip began to swell up was resolved on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Tinnitus
Clinical narrative: An hour after shot I heard a very loud ringing in my left ear that lasted a few seconds and now have gone several days with ringing in both ears much louder than I have ever had in past.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0165) via an unspecified route of administration in the left arm on 05May2021 at 12:45 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included arthritis. The patient received concomitant medication within two weeks of vaccination, but was unspecified. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0165) via an unspecified route of administration in the left arm on 14Apr2021 at 12:45 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 05May2021 at 13:45, an hour after the vaccination, the patient experienced a very loud ringing in the left ear that lasted a few seconds and than had gone several days with ringing in both ears much louder than ever had in the past. Since the vaccination, the patient had been tested for COVID-19. On 06May2021, the patient underwent test via nasal swab test and the result was negative. The clinical outcome of the event loud ringing in left ear was not recovered at the time of this report   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Lymph nodes under the left armpit swollen and very sore; Lymph nodes under the left armpit swollen and very sore; The area around  injection site was sore; A fever; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 08:15 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine.  The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 14:00 (at the age of 28-years-old), as a single dose for COVID-19 immunisation. On 05May2021 at 05:00, at the morning following the second vaccine, the patient woke up to lymph nodes under the left armpit swollen and very sore as well as the area around injection site was sore. Later that day, the patient developed a fever and body aches that lasted for 5 hours. The swollen lymph nodes in her armpit area lasted 4 days and was very sore event after using heating pads. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event lymph nodes very sore that included treatment using heating pads.  Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events fever and body aches was resolved on an unknown date in May2021, after the duration of five hours and lymph nodes under the left armpit swollen was resolved on 09May2021, after the duration of 4 days while that of the events lymph nodes very sore and the area around injection site was sore was resolved on an unknown date in May2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: U
Vaccine: COVID19
Symptoms: Dysgeusia, Heavy menstrual bleeding, Peripheral swelling
Clinical narrative: Leg swelling - really noticeable 4 days after; Metallic taste; Heavy menstrual bleeding; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old patient of unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left leg on 05May2021 at 15:15 (at the age of 52-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not know of any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included paracetamol/ ibuprofen (ADVIL DUAL ACTION) for an unknown indication from an unknown date and unknown if ongoing. On 05May2021, the patient experienced metallic taste right after the shot and experienced heavy menstrual bleeding after shot. On 09May2021, the patient experienced leg swelling and was really noticeable 4 days after, which was on the day of reporting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events metallic taste right after the shot, heavy menstrual bleeding after shot and leg swelling was administered at left leg were unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Body temperature, Chills, Cough, Dysgeusia
Clinical narrative: High fever, reached max to 103.4; Chills; Body ache; Headache; Nausea; Loss of taste; Feel of bitter taste; Dry cough; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 04May2021 at 13:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included dust allergy and cockroach allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 13Apr2021 at 18:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 01:15, the patient experienced high fever that reached maximum to 103.4 (unspecified units), chills, body ache, headache, nausea, loss of taste, feel of bitter taste and dry cough. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL). The clinical outcome of the events high fever that reached maximum to 103.4 (unspecified units), chills, body ache, headache, nausea, loss of taste, feel of bitter taste and dry cough was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia
Clinical narrative: High fever, reached max to 103.4; Chills; Body ache; Headache; Nausea; Loss of taste; Feel of bitter taste; Dry cough; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 04May2021 at 13:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included dust allergy and cockroach allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 13Apr2021 at 18:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 01:15, the patient experienced high fever that reached maximum to 103.4 (unspecified units), chills, body ache, headache, nausea, loss of taste, feel of bitter taste and dry cough. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL). The clinical outcome of the events high fever that reached maximum to 103.4 (unspecified units), chills, body ache, headache, nausea, loss of taste, feel of bitter taste and dry cough was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: My period came a week early the day after my 2nd dose of the vaccine.; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 04May2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05May2021, the day after 2nd dose of the vaccine, the patient's period came a week early. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event period came a week early the day after 2nd dose of the vaccine was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Fatigue, Headache, Lymph node pain
Clinical narrative: Left underarm lymph node is swollen and painful; Fatigue; Underarm lymph node is swollen and painful; Feverish; Pounding headache; Mild stomach discomfort; Chills; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 08May2021 at 10:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient was allergic to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN) and calcium chews (MANUFACTURER UNKNOWN); all medications for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 10:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 08May2021 at 22:15, 12 hours after second vaccine, the patient experienced chills and body aches. On 09May2021, at 01:15, the patient experienced feverish, pounding headache and mild stomach discomfort. On 09May2021, at 16:00, the patient experienced left underarm lymph node is swollen, painful and fatigue. The events did not result in doctor or other healthcare professional office, clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events chills, body aches, feverish, pounding headache, mild stomach discomfort, left underarm lymph node is swollen and painful and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event feverish was resolved on 09May2021 while that of the events chills, body aches, pounding headache, mild stomach discomfort, left underarm lymph node is swollen and painful and fatigue were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Left underarm lymph node is swollen and painful; Fatigue; Underarm lymph node is swollen and painful; Feverish; Pounding headache; Mild stomach discomfort; Chills; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 08May2021 at 10:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient was allergic to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN) and calcium chews (MANUFACTURER UNKNOWN); all medications for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 10:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 08May2021 at 22:15, 12 hours after second vaccine, the patient experienced chills and body aches. On 09May2021, at 01:15, the patient experienced feverish, pounding headache and mild stomach discomfort. On 09May2021, at 16:00, the patient experienced left underarm lymph node is swollen, painful and fatigue. The events did not result in doctor or other healthcare professional office, clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events chills, body aches, feverish, pounding headache, mild stomach discomfort, left underarm lymph node is swollen and painful and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event feverish was resolved on 09May2021 while that of the events chills, body aches, pounding headache, mild stomach discomfort, left underarm lymph node is swollen and painful and fatigue were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pruritus, Pyrexia
Clinical narrative: Body ache; Fever; Headaches; Tiredness; Itching (full body); This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 04May2021 at 17:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included unknown allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within 2 weeks of vaccination. On 05May2021, the patient experienced body ache for 2 days, fever for 1 day, headaches for 4 days, tiredness for 4 days and itching (full body) for 1 day. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever and itching (full body) was resolved on 06May2021; body ache was resolved on 07May2021 while headaches and tiredness was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Eosinophil count, Eosinophil count decreased, Lymphocyte count, Lymphocyte count decreased
Clinical narrative: Absolute lymphocytes and absolute eosinophils counts are low; Absolute lymphocytes and absolute eosinophils counts are low; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 28Mar2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not did not receive any medications within two weeks prior to the COVID-19 vaccine. On an unknown date in Apr2021, the patient experienced absolute lymphocytes and absolute eosinophils counts are low. The patient reported that, according to a recent blood work conducted 3 weeks after the second dose, her absolute lymphocytes and absolute eosinophils counts were low. On an unknown date in Apr2021, the patient underwent blood work absolute lymphocytes and absolute eosinophils counts and the results were low count. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event's absolute lymphocytes and absolute eosinophils counts are low were unknown.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in ears; This is a spontaneous report from a non-contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew01658/21) via an unspecified route of administration in the left arm on 30Apr2021 at 18:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not have medical history and known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021, the patient experienced ringing in ears. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing in ears was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymphadenopathy
Clinical narrative: Severe fatigue; Chills; Headache; Swollen lymph node on the left side of my neck; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 07May2021 at 11:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included quetiapine (MANUFACTURER UNKNOWN) 50 mg , cetirizine hydrochloride (WAL ZYR) 10 mg and famotidine (MANUFACTURER UNKNOWN) 40 mg; all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GR8731) via an unspecified route of administration in the left arm on 16Apr2021 at 11:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient previously received aspartame (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy. On 08May2021 at 08:00, the patient experienced severe fatigue, chills, headache and swollen lymph node on the left side of her neck. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe fatigue, chills, headache and swollen lymph node on the left side of her neck were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hot flush, Nausea
Clinical narrative: Symptoms similar to what "I" experienced when "I" had COVID. Hot flashes with high frequencies; Feel nauseated; Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 22Apr2021, at 09:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19.Patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included hyaluronic acid/glucosamine sulfate/gelatine hydrolysate/ chondroitin sulfate sodium (GLUCOSAMINE CHONDROITIN), amoxicillin (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, at 02:00 the patient experienced symptoms similar to what she experienced when she had COVID, hot flashes with high frequencies, that made her feel nauseated and severe headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hot flashes with high frequencies, that made the patient feel nauseated and severe headache were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen lymph node on left collar bone. It is very painful; Swollen lymph node on left collar bone. It is very swollen; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO0118) via an unspecified route of administration in the left arm on 04May2021 at 12:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0153) via an unspecified route of administration in the left arm on 06Apr2021 at 18:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 12:00, the patient experienced swollen lymph node on left collar bone and it was very painful and swollen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph node on left collar bone and it was very painful and swollen was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Diarrhoea, Dizziness
Clinical narrative: Nausea; Headache; Extreme weakness/ So weak; Dizziness/ dizzy; Fast heart beat (sometimes wake me from sleep); Difficulty breathing; Sore at injection site; Sore muscles and joints; Sore muscles and joints; Chills; Fever; Swollen under arm Lymph node on same side as injection; One time vomiting (possibly unrelated to vaccine); Some diarrhea; Pain in kidney areas, sometimes left side, some time both sides; General feeling sick; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 05May2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to penicillin. Concomitant medications included montelukast (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 05:30, the patient experienced nausea, headache, extreme weakness, dizziness, fast heartbeat (sometimes woke the patient from sleep), difficulty breathing, sore at injection site, sore muscles and joints, chills, fever, general feeling sick, swollen under arm lymph node on same side as injection, one time vomiting (possibly unrelated to vaccine), some diarrhea, pain in kidney areas, sometimes left side, sometime both sides, so weak and dizzy that he had to miss two days of work and too dizzy to drive. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021, the patient underwent antigen test via nasal swab and the result was negative. The clinical outcome of the events nausea, headache, extreme weakness/so weak, dizziness/dizzy, fast heartbeat (sometimes woke the patient from sleep), difficulty breathing, sore at injection site, sore muscles and joints, chills, fever, general feeling sick, swollen under arm lymph node on same side as injection, one time vomiting (possibly unrelated to vaccine), some diarrhea and pain in kidney areas, sometimes left side, sometime both sides was resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Heart rate increased, Lymphadenopathy, Malaise
Clinical narrative: Nausea; Headache; Extreme weakness/ So weak; Dizziness/ dizzy; Fast heart beat (sometimes wake me from sleep); Difficulty breathing; Sore at injection site; Sore muscles and joints; Sore muscles and joints; Chills; Fever; Swollen under arm Lymph node on same side as injection; One time vomiting (possibly unrelated to vaccine); Some diarrhea; Pain in kidney areas, sometimes left side, some time both sides; General feeling sick; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 05May2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to penicillin. Concomitant medications included montelukast (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 05:30, the patient experienced nausea, headache, extreme weakness, dizziness, fast heartbeat (sometimes woke the patient from sleep), difficulty breathing, sore at injection site, sore muscles and joints, chills, fever, general feeling sick, swollen under arm lymph node on same side as injection, one time vomiting (possibly unrelated to vaccine), some diarrhea, pain in kidney areas, sometimes left side, sometime both sides, so weak and dizzy that he had to miss two days of work and too dizzy to drive. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021, the patient underwent antigen test via nasal swab and the result was negative. The clinical outcome of the events nausea, headache, extreme weakness/so weak, dizziness/dizzy, fast heartbeat (sometimes woke the patient from sleep), difficulty breathing, sore at injection site, sore muscles and joints, chills, fever, general feeling sick, swollen under arm lymph node on same side as injection, one time vomiting (possibly unrelated to vaccine), some diarrhea and pain in kidney areas, sometimes left side, sometime both sides was resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Renal pain, SARS-CoV-2 test
Clinical narrative: Nausea; Headache; Extreme weakness/ So weak; Dizziness/ dizzy; Fast heart beat (sometimes wake me from sleep); Difficulty breathing; Sore at injection site; Sore muscles and joints; Sore muscles and joints; Chills; Fever; Swollen under arm Lymph node on same side as injection; One time vomiting (possibly unrelated to vaccine); Some diarrhea; Pain in kidney areas, sometimes left side, some time both sides; General feeling sick; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 05May2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to penicillin. Concomitant medications included montelukast (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 05:30, the patient experienced nausea, headache, extreme weakness, dizziness, fast heartbeat (sometimes woke the patient from sleep), difficulty breathing, sore at injection site, sore muscles and joints, chills, fever, general feeling sick, swollen under arm lymph node on same side as injection, one time vomiting (possibly unrelated to vaccine), some diarrhea, pain in kidney areas, sometimes left side, sometime both sides, so weak and dizzy that he had to miss two days of work and too dizzy to drive. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021, the patient underwent antigen test via nasal swab and the result was negative. The clinical outcome of the events nausea, headache, extreme weakness/so weak, dizziness/dizzy, fast heartbeat (sometimes woke the patient from sleep), difficulty breathing, sore at injection site, sore muscles and joints, chills, fever, general feeling sick, swollen under arm lymph node on same side as injection, one time vomiting (possibly unrelated to vaccine), some diarrhea and pain in kidney areas, sometimes left side, sometime both sides was resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: Nausea; Headache; Extreme weakness/ So weak; Dizziness/ dizzy; Fast heart beat (sometimes wake me from sleep); Difficulty breathing; Sore at injection site; Sore muscles and joints; Sore muscles and joints; Chills; Fever; Swollen under arm Lymph node on same side as injection; One time vomiting (possibly unrelated to vaccine); Some diarrhea; Pain in kidney areas, sometimes left side, some time both sides; General feeling sick; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 05May2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to penicillin. Concomitant medications included montelukast (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 05:30, the patient experienced nausea, headache, extreme weakness, dizziness, fast heartbeat (sometimes woke the patient from sleep), difficulty breathing, sore at injection site, sore muscles and joints, chills, fever, general feeling sick, swollen under arm lymph node on same side as injection, one time vomiting (possibly unrelated to vaccine), some diarrhea, pain in kidney areas, sometimes left side, sometime both sides, so weak and dizzy that he had to miss two days of work and too dizzy to drive. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021, the patient underwent antigen test via nasal swab and the result was negative. The clinical outcome of the events nausea, headache, extreme weakness/so weak, dizziness/dizzy, fast heartbeat (sometimes woke the patient from sleep), difficulty breathing, sore at injection site, sore muscles and joints, chills, fever, general feeling sick, swollen under arm lymph node on same side as injection, one time vomiting (possibly unrelated to vaccine), some diarrhea and pain in kidney areas, sometimes left side, sometime both sides was resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in my ears ( Tinnitus); This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 30Apr2021 at 14:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0130) via an unspecified route of administration in the left arm on 09Apr2021 at 13:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 07May2021, the patient experienced ringing in his ears (tinnitus). The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing in his ears (tinnitus) was not resolved at the time of report.  No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: Right armpit pain on the side of my chest; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 06May2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies.  Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included amfetamine aspartate/ amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) used for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 08Apr2021 at 12:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. On 06May2021 at 20:00, the patient experienced right armpit pain on the side of the chest. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event right armpit pain on the side of the chest. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right armpit pain on the side of the chest was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling abnormal, Headache, Migraine
Clinical narrative: Sore joints; Sore injection site; Large amount Fatigue; Migraine; Headache; Brain fog; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 04May2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 04May2021, the patient experienced sore joints. sore injection site, large amount fatigue, migraine, headache, brain fog, and nausea. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore joints, sore injection site, large amount fatigue, migraine, headache, brain fog, and nausea were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vaccination site pain
Clinical narrative: Sore joints; Sore injection site; Large amount Fatigue; Migraine; Headache; Brain fog; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 04May2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 04May2021, the patient experienced sore joints. sore injection site, large amount fatigue, migraine, headache, brain fog, and nausea. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore joints, sore injection site, large amount fatigue, migraine, headache, brain fog, and nausea were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Lymphadenopathy, Swelling
Clinical narrative: Swelling in neck; Swelling in underarm glands; Swelling on the outer part of of left breast; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 06May2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 08May2021 at 21:30, the patient experienced swelling in neck and underarm glands and swelling on the outer part of left breast. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events swelling in neck and underarm glands and swelling on the outer part of left breast was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.